Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD
<p>Abstract</p> <p>Background</p> <p>Movement disorders (MD) in children are relatively common and may be associated with medication use. Objective methods (ie rating scales) and specific research criteria may be helpful in identifying MD-related adverse events that wou...
Main Authors: | Zhu Young, Bossie Cynthia A, Pandina Gahan J, Gharabawi Georges M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-06-01
|
Series: | Child and Adolescent Psychiatry and Mental Health |
Online Access: | http://www.capmh.com/content/1/1/3 |
Similar Items
-
An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
by: Pandina Gahan, et al.
Published: (2012-06-01) -
Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval
by: Naessens Ineke, et al.
Published: (2007-01-01) -
Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study
by: Wu Jasmanda, et al.
Published: (2009-02-01) -
Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
by: Berry Sally A, et al.
Published: (2008-06-01) -
Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
by: Jeffrey R Bishop, et al.
Published: (2008-03-01)